[Significance of some changes induced in the vasoactive systems of renin and kallikrein during diuretic treatment of arterial hypertension].
作者信息
Covi G, Pedrolli E, Dalla Riva S, Danti G, Lechi C, Minuz P, Mattioli M, Lechi A
出版信息
G Clin Med. 1980 Feb;61(2):134-47.
PMID:7004976
Abstract
摘要
相似文献
1
2
[The significance of urinary kallikrein excretion during treatment of hypertension with diuretics].[利尿剂治疗高血压期间尿激肽释放酶排泄的意义]
Med Welt. 1979 Dec 22;30(51-52):1926-7.
3
[Urinary kallikrein and plasma renin levels in patients with secondary hypertension].继发性高血压患者的尿激肽释放酶和血浆肾素水平
Pol Tyg Lek. 1984 Mar 5;39(10):325-8.
4
5
[Urinary kallikrein excretion in primary arterial hypertension].[原发性动脉高血压患者的尿激肽释放酶排泄情况]
Kardiol Pol. 1981;24(10):657-64.
6
[Treatment of arterial hypertension patients depending on renin activity].[根据肾素活性治疗动脉高血压患者]
Vrach Delo. 1984 Feb(2):61-5.
7
Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.培哚普利治疗对原发性高血压患者血浆及尿液中激肽释放酶活性和前列腺素E2稳定代谢产物的影响。
Methods Find Exp Clin Pharmacol. 1996 Apr;18(3):205-9.
8
9
Effects of bumetanide upon PRA and urinary kallikrein excretion in normal subjects before and after indomethacin treatment.布美他尼对消炎痛治疗前后正常受试者血浆肾素活性（PRA）和尿激肽释放酶排泄的影响。
Minerva Nefrol. 1980 Jul-Sep;27(3):421-4.
10
Zotero 插件